Similarly, although experimental studies indicated that adiponectin increased HCC apoptosis and prevented liver tumor growth and metastasis, increased adiponectin has also been associated with both favorable prognosis [56] and reduced HCC survival [57]. This evidence concerns the gene ADIPOQ and hepatocellular carcinoma.